论文期刊

取消

高级检索

检索历史清除

首页> European journal of pharmacology> K303⁶·⁵⁸ in the μ opioid (MOP) receptor is important in conferring selectivity for covalent binding of β-funaltrexamine (β-FNA).

K303⁶·⁵⁸ in the μ opioid (MOP) receptor is important in conferring selectivity for covalent binding of β-funaltrexamine (β-FNA).

导出 OA

翻译打印收藏纠错

作者： Kelly M,DiMattio ^[1] ; Chongguang,Chen ^[2] ; Lei,Shi ^[3] ; Lee-Yuan,Liu-Chen ^[4]

作者单位： Center for Substance Abuse Research and Department of Pharmacology, Temple University School of Medicine, 3500 N. Broad Street, MERB 851, Philadelphia, PA 19140, United States. Electronic address: kelly.dimattio@temple.edu. ^[1] Center for Substance Abuse Research and Department of Pharmacology, Temple University School of Medicine, 3500 N. Broad Street, MERB 851, Philadelphia, PA 19140, United States. Electronic address: cgggc@temple.edu. ^[2] Department of Physiology and Biophysics, Institute for Computational Biomedicine, Weill Medical College of Cornell University, 1300 York Ave., Box 75, New York, NY 10065, United States. Electronic address: les2007@med.cornell.edu. ^[3] Center for Substance Abuse Research and Department of Pharmacology, Temple University School of Medicine, 3500 N. Broad Street, MERB 851, Philadelphia, PA 19140, United States. Electronic address: lliuche@temple.edu. ^[4]

关键词 Irreversible binding Kappa opioid receptor Mu opioid receptor β-funaltrexamine

主题词动物(Animals);细胞系, 肿瘤(Cell Line, Tumor);保守序列(Conserved Sequence);细胞外间隙(Extracellular Space);人类(Humans);赖氨酸(Lysine);小鼠(Mice);突变(Mutation);纳曲酮(Naltrexone);麻醉品拮抗药(Narcotic Antagonists);蛋白质结合(Protein Binding);蛋白质构象(Protein Conformation);大鼠(Rats);受体, 阿片样, κ(Receptors, Opioid, kappa);受体, 阿片样, μ(Receptors, Opioid, mu);底物特异性(Substrate Specificity)

DOI 10.1016/j.ejphar.2014.11.028

PMID 25481857

发布时间 2018-11-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

European journal of pharmacology

93-100页

相似文献

中文期刊
外文期刊
学位论文
会议论文

特别提示：本网站仅提供医学学术资源服务，不销售任何药品和器械，有关药品和器械的销售信息，请查阅其他网站。

客服热线：4000-115-888 转3 (周一至周五：8:00至17:00)
|
客服邮箱：yiyao@wanfangdata.com.cn

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

官方微信

万方医学小程序

关于我们网站地图知识产权

北京万方数据股份有限公司

万方数据电子出版社

京ICP证010071号

京公网安备11010802020237号

京ICP备08100800号-1

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

new翻译充值订阅收藏移动端

官方微信

万方医学小程序

调查问卷